Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

LCZ-696 granted accelerated assessment by CHMP in Europe

Dec. 1, 2014

Osteopontin RNA aptamer shows potential for the treatment of heart failure

Dec. 1, 2014

Recombinant human placental growth factor as promising therapy for artherosclerosis

Nov. 28, 2014

Milestone Pharmaceuticals reports phase I data for MSP-2017

Nov. 27, 2014

Modified human cardiac stem cells overexpressing SDF-1-alpha enhance cardiac repair

Nov. 26, 2014

Vorapaxar receives positive opinion from EMA

Nov. 25, 2014

EMA issues new recommendations for the use of Corlentor/Procoralan

Nov. 25, 2014

Proteo discloses results from phase II study of Elafin in myocardial reperfusion injury

Nov. 25, 2014

Sanquin and Okklo collaborate to develop cyclodextrins for cardiovascular indications

Nov. 24, 2014

Arena Pharmaceuticals reports development of Mas receptor modulators

Nov. 21, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AACR D3: ONM-421 shows antigen-independent tumor control
BioWorld Science
At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...